Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


MEDTRONIC   FYE=4 (April)

Annual - Income Statement - Company Specific

Fiscal period2019201820172016201520142013201220112010
Period End Date4/30/20194/30/20184/30/20174/30/20164/30/20154/30/20144/30/20134/30/20124/30/20114/30/2010
Net Sales30,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.0016,184.0015,508.0015,392.00
Total Revenue30,557.0029,953.0029,710.0028,833.0020,261.0017,005.0016,590.0016,184.0015,508.0015,392.00
Cost of Products Sold9,155.009,067.009,294.009,142.006,309.004,333.004,126.003,889.003,700.003,582.00
Amortization of intangible assets1,764.001,823.001,980.001,931.00733.00349.00331.00335.00339.00317.00
Research and development expense2,330.002,256.002,193.002,224.001,640.001,477.001,557.001,490.001,472.001,424.00
Purchased in-process research and development charges--------------------
Selling, general and administrative expense10,418.0010,238.0010,018.009,469.006,904.005,847.005,698.005,623.005,427.005,282.00
Restructuring charges198.0030.00303.00290.00237.0078.00172.0087.00259.0050.00
Acquisition-related items------283.00550.00117.00(49.00)12.0014.0023.00
Certain litigation charges, net166.0061.00300.0026.0042.00770.00--------
Non-recurring charges--------------------
Special charges--------38.00(40.00)--------
Gain on sale of businesses--697.00----------------
Other income (expense) net(258.00)(535.00)(239.00)(107.00)(118.00)(181.00)--------
Operating Profit6,268.006,640.005,383.005,361.003,766.003,813.00--------
Interest expense--------666.00379.00151.00349.00450.00402.00
Interest income--------(386.00)(271.00)(237.00)(200.00)(172.00)(156.00)
Interest expense1,444.001,146.001,094.001,386.00280.00108.00151.00149.00278.00246.00
Special charges--------------------
Certain litigation charges------------245.0090.00245.00374.00
Investment loss------(70.00)------------
Interest income, net373.00181.00313.00431.00------------
Other income (expense) net------------(108.00)(364.00)(110.00)(150.00)
Earnings before income taxes5,197.005,675.004,602.004,336.003,486.003,705.004,251.004,145.003,664.003,944.00
Provision for income taxes547.002,580.00578.00798.00811.00640.00784.00730.00609.00861.00
Current tax expense: U.S579.002,899.00614.00440.001,128.00532.00509.00664.00360.00515.00
Current tax expense: International406.00796.00840.00835.00502.00248.00219.00231.00188.00237.00
Deferred tax expense ( U.S(310.00)45.00(399.00)(67.00)(705.00)(175.00)46.00(138.00)51.00111.00
Deferred tax expense ( International(128.00)(1,160.00)(477.00)(410.00)(114.00)35.0010.00(27.00)10.00(2.00)
Tax expense recorded directly in shareholders" equity--------------------
Income (loss) from Continuing Operations--------------3,415.003,055.003,083.00
Earnings from discontinued operations------------------16.00
Discontinued operations- Physio-Control divestiture-related costs--------------(34.00)(2.00)--
Discontinued operations- Gain on sale of Physio-Control--------------204.00----
Discontinued operations- Earnings from operations of Physio-Control--------------32.0043.00--
Net income4,650.003,095.004,024.003,538.002,675.00----------
Net income (loss) attributable to noncontrolling interests19.00(9.00)(4.00)--------------
Net earnings allocable to Common Units4,631.003,104.004,028.003,538.002,675.003,065.003,467.003,617.003,096.003,099.00
Earnings from continuing operations (Basic)--------------3.242.842.79
EPS (BASIC): Earnings from discontinued operations----------------0.040.01
Net Earnings Per Share (Basic)3.442.292.922.512.443.063.403.432.872.80
Earnings from continuing operations (Diluted)----------------2.822.78
EPS (DILUTED): Earnings from discontinued operations----------------0.040.01
Net Earnings Per Share (Diluted)3.412.272.892.482.413.023.373.412.862.79
Weighted Average Shares Outstanding (Basic)1,346.401,356.701,378.901,409.601,095.501,002.101,019.301,053.901,077.401,106.30
Weighted Average Shares Outstanding (Diluted)1,357.501,368.201,391.401,425.901,109.001,013.601,027.501,059.901,081.701,109.40